Ma Yixiao, Liu Hua, Wang Yong, Xuan Junjie, Gao Xing, Ding Huixian, Ma Chunlian, Chen Yanfang, Yang Yi
Graduate School, Wuhan Sports University, Wuhan, 430079, China.
Laboratory of Physical Fitness Monitoring & Chronic Disease Intervention, Wuhan Sports University, Wuhan, 430079, China.
Diabetol Metab Syndr. 2022 Nov 14;14(1):169. doi: 10.1186/s13098-022-00942-6.
Although physical activity is widely recommended for preventing and treating cardiovascular complications of type 2 diabetes mellitus (T2DM), the underlying mechanisms remain unknown. MicroRNA-126 (miR-126) is an angiogenetic regulator abundant in endothelial cells (ECs) and endothelial progenitor cells (EPCs). It is primarily involved in angiogenesis, inflammation and apoptosis for cardiovascular protection. According to recent studies, the levels of miR-126 in the myocardium and circulation are affected by exercise protocol. High-intensity interval training (HIIT) or moderate-and high-intensity aerobic exercise, whether acute or chronic, can increase circulating miR-126 in healthy adults. Chronic aerobic exercise can effectively rescue the reduction of myocardial and circulating miR-126 and vascular endothelial growth factor (VEGF) in diabetic mice against diabetic vascular injury. Resistance exercise can raise circulating VEGF levels, but it may have a little influence on circulating miR-126. The Several targets of miR-126 have been suggested for cardiovascular fitness, such as sprouty-related EVH1 domain-containing protein 1 (SPRED1), phosphoinositide-3-kinase regulatory subunit 2 (PIK3R2), vascular cell adhesion molecule 1 (VCAM1), high-mobility group box 1 (HMGB1), and tumor necrosis factor receptor-associated factor 7 (TRAF7). Here, we present a comprehensive review of the roles of miR-126 and its downstream proteins as exercise mechanisms, and propose that miR-126 can be applied as an exercise indicator for cardiovascular prescriptions and as a preventive or therapeutic target for cardiovascular complications in T2DM.
尽管广泛推荐通过体育活动来预防和治疗2型糖尿病(T2DM)的心血管并发症,但其潜在机制仍不清楚。微小RNA-126(miR-126)是一种在内皮细胞(ECs)和内皮祖细胞(EPCs)中丰富的血管生成调节因子。它主要参与血管生成、炎症和细胞凋亡以保护心血管。根据最近的研究,运动方案会影响心肌和循环中miR-126的水平。高强度间歇训练(HIIT)或中等强度和高强度有氧运动,无论是急性还是慢性,都能增加健康成年人循环中的miR-126。慢性有氧运动可以有效挽救糖尿病小鼠心肌和循环中miR-126以及血管内皮生长因子(VEGF)的减少,以对抗糖尿病血管损伤。抗阻运动可以提高循环VEGF水平,但对循环miR-126可能影响较小。已提出miR-126的几个靶标对心血管健康有益,如含Sprouty相关EVH1结构域蛋白1(SPRED1)、磷酸肌醇-3-激酶调节亚基2(PIK3R2)、血管细胞黏附分子1(VCAM1)、高迁移率族蛋白B1(HMGB1)和肿瘤坏死因子受体相关因子7(TRAF7)。在此,我们全面综述了miR-126及其下游蛋白作为运动机制的作用,并提出miR-126可作为心血管处方的运动指标以及T2DM心血管并发症的预防或治疗靶点。